Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Advanced Medical Isotope Corporation (RDGL) Debt to Equity Ratio data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.07M |
|
$-3.07M |
|
$0.13M |
|
$-0.06M |
|
$3.23M |
|
$-3.17M |
|
$0.10M |
|
$-3.07M |
|
$-3.07M |
|
$-3.07M |
|
$-3.07M |
|
$-3.07M |
|
$-3.07M |
|
$-3.17M |
|
$-3.16M |
|
452.72M |
|
452.72M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$1.65M |
|
$0.10M |
|
$0.22M |
|
$1.87M |
|
$0.12M |
|
-- |
|
$0.09M |
|
$0.21M |
|
$-7.69M |
|
$1.66M |
|
$1.66M |
|
455.49M |
|
| Cash Flow Statement Financials | |
$-2.06M |
|
$-0.10M |
|
$1.51M |
|
$2.21M |
|
$1.56M |
|
$-0.65M |
|
$1.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.00 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-87.39% |
|
-4628.68% |
|
-4628.68% |
|
-4628.14% |
|
-4483.86% |
|
-4483.86% |
|
$-2.16M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
2.24 |
|
3.06 |
|
119.20 |
|
39.87% |
|
-184.61% |
|
-164.17% |
|
-184.61% |
|
$0.00 |
|
$-0.00 |
|
$-0.00 |
|